Because the basal expression levels of BTN1A1, BTNL2, BTNL3, and BTNL8 were relatively low, in further analysis, we only focused on the expression of BTN2/3 subfamilies in pan-gliomas (Figure 1B). This evidence concerns the gene BTNL2 and central nervous system cancer.